federal_register: 2013-07296
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-07296 | Draft Guidance for Industry on Bioequivalence Recommendations for Metronidazole Vaginal Gel; Availability | Notice | The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Bioequivalence Recommendations for Metronidazole Vaginal Gel." The guidance provides specific recommendations on the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs) for metronidazole vaginal gel. | 2013-03-29 | 2013 | 3 | https://www.federalregister.gov/documents/2013/03/29/2013-07296/draft-guidance-for-industry-on-bioequivalence-recommendations-for-metronidazole-vaginal-gel | https://www.govinfo.gov/content/pkg/FR-2013-03-29/pdf/2013-07296.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Bioequivalence Recommendations for Metronidazole Vaginal Gel." The guidance provides specific recommendations on the design of... |